Q2 2020 13F Holders as of 30 Jun 2020
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
44.8M
-
Number of holders
-
338
-
Total 13F shares, excl. options
-
42.1M
-
Shares change
-
-891K
-
Total reported value, excl. options
-
$5.09B
-
Value change
-
-$63.2M
-
Put/Call ratio
-
0.77
-
Number of buys
-
187
-
Number of sells
-
-141
-
Price
-
$121.00
Significant Holders of UNITED THERAPEUTICS Corp - Common Stock (UTHR) as of Q2 2020
395 filings reported holding UTHR - UNITED THERAPEUTICS Corp - Common Stock as of Q2 2020.
UNITED THERAPEUTICS Corp - Common Stock (UTHR) has 338 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 42.1M shares
of 44.8M outstanding shares and own 93.87% of the company stock.
Largest 10 shareholders include BlackRock Inc. (4.52M shares), VANGUARD GROUP INC (4.03M shares), RENAISSANCE TECHNOLOGIES LLC (3.73M shares), FMR LLC (2.52M shares), STATE STREET CORP (1.51M shares), ACADIAN ASSET MANAGEMENT LLC (1.21M shares), ADAGE CAPITAL PARTNERS GP, L.L.C. (1.1M shares), AQR CAPITAL MANAGEMENT LLC (932K shares), CITADEL ADVISORS LLC (880K shares), and DIMENSIONAL FUND ADVISORS LP (793K shares).
This table shows the top 338 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.